Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Barrett

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
ACS Infectious Diseases|February 10, 2021
Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Rama S R Vidadala, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2025
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controlsNeda Sattarnezhad, Ingrid Kockum, Olivia G Thomas, et al.
Critical Care (London, England)|October 24, 2017
Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational studyJohannes Ehler, Lucinda K Barrett, Valerie Taylor, et al.
Scientific Reports|November 5, 2021
The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug designIsabelle Q Phan, Christopher A Rice, Justin Craig, et al.
Diabetes, Obesity & Metabolism|May 27, 2020
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort studyEric Y F Wan, Esther Y T Yu, Weng Y Chin, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Viruses|May 27, 2023
Detection of SARS-CoV-2 in Terrestrial Animals in Southern Nigeria: Potential Cases of Reverse ZoonosisAnise N Happi, Akeemat O Ayinla, Olusola A Ogunsanya, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 11, 2025
Crystal structure of a short-chain dehydrogenase from Brucella ovis with apo and coenzyme NAD<sup>+</sup>-bound protomer chainsSean P Zupko, Amelia T Konstanty, Steve J Mayclin, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
ACS Infectious Diseases|February 10, 2021
Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Rama S R Vidadala, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2025
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controlsNeda Sattarnezhad, Ingrid Kockum, Olivia G Thomas, et al.
Critical Care (London, England)|October 24, 2017
Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational studyJohannes Ehler, Lucinda K Barrett, Valerie Taylor, et al.
Scientific Reports|November 5, 2021
The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug designIsabelle Q Phan, Christopher A Rice, Justin Craig, et al.
Diabetes, Obesity & Metabolism|May 27, 2020
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort studyEric Y F Wan, Esther Y T Yu, Weng Y Chin, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Viruses|May 27, 2023
Detection of SARS-CoV-2 in Terrestrial Animals in Southern Nigeria: Potential Cases of Reverse ZoonosisAnise N Happi, Akeemat O Ayinla, Olusola A Ogunsanya, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 11, 2025
Crystal structure of a short-chain dehydrogenase from Brucella ovis with apo and coenzyme NAD<sup>+</sup>-bound protomer chainsSean P Zupko, Amelia T Konstanty, Steve J Mayclin, et al.
Pageof 32